A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression
/in International Publications, Malignant Melanoma /von 2008-01-25 / J Transl Med 2008 Jan;6:6Dendritic cells in patients with melanoma
/in International Publications, Malignant Melanoma /von 2008-01-23 / Ann. Surg. Oncol. 2008 Jun;15(6):1807Efficient monocyte-derived dendritic cell generation in patients with acute myeloid leukemia after chemotherapy treatment: application to active immunotherapy
/in Acute Leukemia, International Publications /von 2008-01-22 / Exp. Hematol. 2008 Mar;36(3):329-39Therapeutic dendritic cell vaccine preparation using tumor RNA transfection: a promising approach for the treatment of prostate cancer
/in International Publications, Prostate Cancer /von 2008-01-18 / Genet Vaccines Ther 2008 Jan;6:2Generation of a recombinant oncolytic Newcastle disease virus and expression of a full IgG antibody from two transgenes
/in International Publications, Newcastle Disease Virus /von 2008-01-17 / Gene Ther. 2008 Mar;15(5):371-83Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia
/in Acute Leukemia, International Publications /von 2008-01-15 / Transfusion 2008 May;48(5):861-70Dendritic cells transduced with a PSMA-encoding adenovirus and cocultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against prostate cancer cells
/in International Publications, Prostate Cancer /von 2008-01-14 / Urol. Oncol. 2009 Jan-Feb;27(1):26-32Monocyte derived dendritic cells retain their functional capacity in patients following infection with hepatitis C virus
/in Chronic Virus Hepatitis, International Publications /von 2008-01-10 / J. Viral Hepat. 2008 Mar;15(3):219-28A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors
/in Dendritic Cells, Gallbladder Cancer, International Publications, Pancreatic Cancer /von 2008-01-01 / Cancer Ther 2008;6(B):955-964
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution